Technical Analysis for MNK - Mallinckrodt plc

Grade Last Price % Change Price Change
grade A 30.86 -1.81% -0.57
MNK closed down 1.81 percent on Friday, November 16, 2018, on 58 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical MNK trend table...

Date Alert Name Type % Chg
Nov 16 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Nov 16 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Nov 16 NR7 Range Contraction 0.00%
Nov 16 Inside Day Range Contraction 0.00%
Nov 16 Wide Bands Range Expansion 0.00%
Nov 16 Overbought Stochastic Strength 0.00%
Nov 15 Pocket Pivot Bullish Swing Setup -1.81%
Nov 15 Outside Day Range Expansion -1.81%
Nov 15 Wide Bands Range Expansion -1.81%
Nov 15 Overbought Stochastic Strength -1.81%

Older signals for MNK ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Mallinckrodt public limited company develops, manufactures, markets, and distributes branded and generic specialty pharmaceuticals, active pharmaceutical ingredients (API), and diagnostic imaging agents worldwide. The company's Specialty Pharmaceuticals segment offers EXALGO extended-release tablets to treat pain in opioid-tolerant patients; and GABLOFEN injections indicated for use in the management of spasticity of cerebral or spinal origin in patients age four years and above. This segment also provides generic drugs, such as oxycodone or in combination with acetaminophen, as well as hydrocodone, which in combination with acetaminophen to treat pain; and methylphenidate to treat attention deficit hyperactivity disorder. This segment markets its branded products to physicians, including pain specialists, anesthesiologists, orthopedic surgeons, rheumatologists, and neurologists; and generic products to wholesalers, large- and medium-sized retail pharmacy chains, food store chains with pharmacies, mail order pharmacies, and other channels of distribution. Its Global Medical Imaging segment provides contrast media and delivery systems comprising iodine- and gadolinium-containing injectable products for diagnostic imaging applications, such as computed tomography and magnetic resonance imaging under the Optiray and Optimark brand names. This segment also offers nuclear imaging agents consisting of Technescan MAG3, a nuclear imaging agent to detect and evaluate a range of renal disorders; technetium-99m for use in Ultra-Technekow DTE generators; cold kits; and other radiopharmaceuticals, such as Octreoscan to detect cancer. This segment sells its contrast media systems to hospitals and hospital groups; branded products directly to managed care organizations; and API products to other pharmaceutical companies. The company was incorporated in 2013 and is based in Dublin, Ireland. Mallinckrodt plc (NYSE:MNK) operates independently of Covidien plc as of June 28, 2013.
Is MNK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 36.65
52 Week Low 11.65
Average Volume 2,074,731
200-Day Moving Average 21.8724
50-Day Moving Average 28.6248
20-Day Moving Average 28.2995
10-Day Moving Average 30.549
Average True Range 1.4627
ADX 30.31
+DI 24.4556
-DI 12.6097
Chandelier Exit (Long, 3 ATRs ) 27.9519
Chandelier Exit (Short, 3 ATRs ) 29.3181
Upper Bollinger Band 33.2377
Lower Bollinger Band 23.3613
Percent B (%b) 0.76
BandWidth 34.899557
MACD Line 0.9661
MACD Signal Line 0.5149
MACD Histogram 0.4512
Fundamentals Value
Market Cap 2.99 Billion
Num Shares 97 Million
EPS -4.63
Price-to-Earnings (P/E) Ratio -6.67
Price-to-Sales 0.92
Price-to-Book 0.59
PEG Ratio 0.79
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 32.11
Resistance 3 (R3) 32.18 31.83 31.90
Resistance 2 (R2) 31.83 31.52 31.80 31.83
Resistance 1 (R1) 31.35 31.32 31.18 31.28 31.76
Pivot Point 31.00 31.00 30.92 30.97 31.00
Support 1 (S1) 30.52 30.69 30.35 30.45 29.96
Support 2 (S2) 30.17 30.49 30.14 29.89
Support 3 (S3) 29.69 30.17 29.82
Support 4 (S4) 29.62